contract pharmaceutical

Greg Fenton Discusses Zentek’s 2024 Progress and Exclusive Aptamer Technology Rights

In a detailed interview with Tracy Weslosky, Greg Fenton, CEO and Director of Zentek Ltd. (NASDAQ: ZTEK |…